DaVita HealthCare Partners Inc (DVA): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

DaVita HealthCare Partners ( DVA) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, DaVita HealthCare Partners rose $1.35 (1.1%) to $118.55 on average volume. Throughout the day, 589,344 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 777,900 shares. The stock ranged in a price between $117.16-$118.69 after having opened the day at $117.21 as compared to the previous trading day's close of $117.20. Other companies within the Health Services industry that increased today were: Dynatronics Corporation ( DYNT), up 18.7%, Kips Bay Medical ( KIPS), up 16%, NeuroMetrix ( NURO), up 9.9%, and Addus Homecare Corporation ( ADUS), up 7.7%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.38 billion and is part of the health care sector. The company has a P/E ratio of 21.5, above the S&P 500 P/E ratio of 17.7. Shares are up 6% year to date as of the close of trading on Wednesday. Currently there are eight analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and five rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, increase in net income, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins.

On the negative front, Strategic Diagnostics ( SDIX), down 8.3%, Navidea Biopharmaceuticals ( NAVB), down 7.9%, Uroplasty ( UPI), down 7.8%, and Orthofix International N.V ( OFIX), down 4.8%, were all laggards within the health services industry with Express Scripts ( ESRX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.